SMC021 Oral Calcitonin
CSMC021C2301
Phase 3 small_molecule completed
Quick answer
SMC021 Oral Calcitonin for Osteoarthritis is a Phase 3 program (small_molecule) at Nordic Bioscience A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nordic Bioscience A/S
- Indication
- Osteoarthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed